Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Benznidazole 100 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Benznidazole 12.5 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Triclabendazole 250 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cedazuridine 100 mg and decitabine 35 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cedazuridine 100 mg and decitabine 35 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Miltefosine 50 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amphotericin B liposome 50 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Agomelatine 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
fenazon 50 mg/ml, örondroppar, lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Bisacodyl 2 mg/mL rectal suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cinnarizine 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Brivaracetam 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Brivaracetam 50 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Brivaracetam 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Brivaracetam 100 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Brigatinib 30 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Binimetinib 15 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Baricitinib 2 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Baricitinib 4 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Calcium carbonate 900 mg/g cutaneous powder |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
prednisolonacetat 1,2 mg/ml, ögondroppar, suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
pilokarpinnitrat 20 mg/ml, ögondroppar, lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 2.42 mg/mL oral solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely calcium acetate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Bilastine 20 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
tetrakainhydroklorid 10 mg/ml, ögondroppar, lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
tetrakainhydroklorid 5 mg/ml, ögondroppar, lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Benzyl benzoate 250 mg/mL cutaneous emulsion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Mifepristone 600 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Nicotinic acid 500 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Clotrimazole 200 mg vaginal pessary |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Miconazole 20 mg/g oral gel |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Calcium undecylenate 100 mg/g cutaneous powder |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
propamidinisetionat 1 mg/ml, ögondroppar, lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Wool alcohol 2 mg/g eye ointment |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg effervescent oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Soya oil refined 200 mg/mL emulsion for infusion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely soya oil refined 100 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Alectinib (as alectinib hydrochloride) 150 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Vandetanib 300 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Fedratinib (as fedratinib hydrochloride) 100 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely sonidegib (as sonidegib phosphate) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely ribociclib (as ribociclib succinate) 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Trametinib (as trametinib dimethyl sulfoxide) 2 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cannabidiol 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely pralatrexate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Mepolizumab 100 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 500 milligram/1 each tablet for conventional release oral solution (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Metoprolol tartrate 1 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Trastuzumab emtansine 100 mg powder for solution for infusion vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely calcium polystyrene sulfonate 999.34 milligram/1 gram powder for conventional release oral or rectal suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely potassium chloride 75 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |